Special lenses or eyedrops: which slows nearsightedness better in kids?

NCT ID NCT05062031

Ongoing Disease control Sponsor: Fondation Ophtalmologique Adolphe de Rothschild Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether special glasses called DIMS lenses can slow the worsening of nearsightedness (myopia) in children as well as low-dose atropine eyedrops do. About 242 children aged 6-12 with myopia will wear either DIMS lenses or regular glasses plus use atropine drops nightly for two years. The goal is to see which approach better controls eye growth and prescription changes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Atropine 0.05% eyedrops and Defocus Incorporated Multiple Segments (DIMS) lenses
What this could lead to: If successful, this could show that DIMS lenses alone are as effective as atropine eyedrops for controlling myopia in children, offering a drug-free option.
What could go wrong: This is a single-center study with 242 participants, and results may not apply to all children. Atropine can cause light sensitivity and blurred near vision, and DIMS lenses may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA

Contacts and locations

Locations

Hôpital Fondation Adolphe de Rothschild

Paris, 75019, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.